ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesChapter 5: Mental, Behavioral and Neurodevelopmental disordersF12

F12

Billable

Cannabis related disorders

Chapter 5:Mental, Behavioral and Neurodevelopmental disorders

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 F12 is a billable code used to indicate a diagnosis of cannabis related disorders.

Key Diagnostic Point:

Cannabis-related disorders encompass a range of conditions resulting from the use of cannabis, including cannabis use disorder, cannabis intoxication, and cannabis withdrawal syndrome. Cannabis use disorder is characterized by a problematic pattern of cannabis use leading to significant impairment or distress, manifesting in symptoms such as cravings, tolerance, and withdrawal. Intoxication symptoms may include altered mental status, impaired coordination, and anxiety. Withdrawal symptoms can occur after cessation of prolonged use and may include irritability, sleep disturbances, and decreased appetite. Treatment options often involve behavioral therapies, counseling, and support groups, with some cases requiring pharmacological interventions. The clinical approach to cannabis-related disorders necessitates a comprehensive assessment of the patient's history, usage patterns, and any co-occurring mental health conditions, ensuring a tailored treatment plan that addresses both the substance use and any underlying psychological issues.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of symptoms associated with intoxication and withdrawal
  • Need for differentiation between use disorder and other mental health conditions
  • Variability in state laws regarding cannabis use and its implications for treatment
  • Documentation requirements for treatment programs and behavioral therapies

Audit Risk Factors

  • Inadequate documentation of the severity of the disorder
  • Failure to document co-occurring mental health conditions
  • Misclassification of intoxication versus withdrawal symptoms
  • Lack of evidence for treatment interventions provided

Specialty Focus

Medical Specialties

Addiction Medicine

Documentation Requirements

Comprehensive assessment of substance use history, including frequency and quantity of cannabis use, and any co-occurring disorders.

Common Clinical Scenarios

Patients presenting with withdrawal symptoms, those seeking treatment for cannabis use disorder, or individuals with co-occurring mental health issues.

Billing Considerations

Ensure accurate documentation of treatment plans and patient progress to support the diagnosis and coding.

Psychiatry

Documentation Requirements

Detailed mental health evaluations, including assessment of mood, anxiety, and cognitive function related to cannabis use.

Common Clinical Scenarios

Patients with anxiety or mood disorders exacerbated by cannabis use, or those experiencing psychosis related to cannabis intoxication.

Billing Considerations

Documenting the impact of cannabis on mental health and any therapeutic interventions provided.

Coding Guidelines

Inclusion Criteria

Use F12 When
  • Follow the official ICD
  • CM coding guidelines for substance use disorders, ensuring accurate documentation of the severity and type of cannabis
  • related disorder
  • Include any relevant co
  • occurring conditions and specify the treatment interventions provided

Exclusion Criteria

Do NOT use F12 When
No specific exclusions found.

Related CPT Codes

H0001CPT Code

Behavioral health assessment

Clinical Scenario

Used when assessing a patient for cannabis use disorder.

Documentation Requirements

Document the assessment findings, including substance use history and mental health evaluation.

Specialty Considerations

Addiction specialists should ensure comprehensive evaluations are conducted.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of cannabis-related disorders, enabling better tracking of prevalence and treatment outcomes. This specificity aids in research and improves the quality of care provided to patients.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of cannabis-related disorders, enabling better tracking of prevalence and treatment outcomes. This specificity aids in research and improves the quality of care provided to patients.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of cannabis-related disorders, enabling better tracking of prevalence and treatment outcomes. This specificity aids in research and improves the quality of care provided to patients.

Resources

Clinical References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)
  • •
    National Institute on Drug Abuse (NIDA)

Coding & Billing References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)
  • •
    National Institute on Drug Abuse (NIDA)

Frequently Asked Questions

What is the difference between cannabis use disorder and cannabis dependence?

Cannabis use disorder is a broader term that encompasses various levels of problematic use, including dependence. Dependence specifically refers to the physiological adaptation to cannabis, characterized by tolerance and withdrawal symptoms.

How do I document cannabis withdrawal symptoms?

Document the specific symptoms experienced by the patient, their duration, and the impact on daily functioning. Include any interventions provided to manage withdrawal symptoms.